£76.69

This is the most expensive it has ever been. Walk away.

£77 today · previous high £77 · all-time low £77

Hayle Medical Encyclopedia of Parkinson's Disease: Volume VIII (Advanced Therapies): 8

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days · 35 data points (no recent data)

Historical
Generating forecast…
£76.69 £76.48 £76.53 £76.57 £76.62 £76.66 £76.71 12 August 2026 20 August 2026 29 August 2026 06 September 2026 15 September 2026
View at Amazon ↗

Price data last checked 56 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price
35 days 0 9 18 26 35 £77 Days at Price

Price Analysis

Most common price: £77 (35 days, 100.0%)

Price range: £77 - £77

Price levels: 1 different prices over 35 days

Description

The advanced therapies in the field of Parkinson's disease (PD) are discussed extensively in this book. This disease is clinically characterized by distinct progressive motor and non-motor symptoms, pathologically due to loss of dopamine generating cells and intra-neuronal cytoplasmic inclusions comprised mainly of synuclein. A considerable proportion of the cells in the substantia nigra are already lost before patients are first diagnosed with even the earliest symptoms of PD at the clinic. This damage continues irrespective of the available therapies until the cell loss is so high that the quality of normal life is endangered. The dopamine precursor levodopa is the most important drug presently available for the treatment of PD. Nevertheless, for most PD patients, the optimum clinical benefit from levodopa reduces after about five to six years of treatment. The aim of this book is to provide the readers with a comprehension regarding the mechanisms of degeneration as well as formulation of disease modifying therapies.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
83% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 22 Oct 2026
Levodopa-Induced Dyskinesia in Parkinson's Disease
81% match

Levodopa-Induced Dyskinesia in Parkinson's Disease

Springer

£84.46 15 Sep 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
81% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£62.45 21 Oct 2026
Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice
81% match

Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice

Elsevier

£137.99 21 Oct 2026
Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management
80% match

Advanced and Integrative Therapeutic Strategies in Parkinson’s Disease Management

Elsevier

£133.99 22 Oct 2026
Time to Prevent Parkinson's Disease
79% match

Time to Prevent Parkinson's Disease

£105.16 15 Sep 2026
Diagnosis and Treatment of Parkinson’s Disease ― State of the Art: 56 (Journal of Neural Transmission. Supplementa, 56)
79% match

Diagnosis and Treatment of Parkinson’s Disease ― State of the Art: 56 (Journal of Neural Transmission. Supplementa, 56)

Springer

£132.71 30 Aug 2026
Cognitive Impairment and Dementia in Parkinson's Disease
79% match

Cognitive Impairment and Dementia in Parkinson's Disease

Oxford University Press

£113.96 15 Sep 2026
Noves formes farmacèutiques i vies d'administració de levodopa: per al tractament de la malaltia de Parkinson
78% match

Noves formes farmacèutiques i vies d'administració de levodopa: per al tractament de la malaltia de Parkinson

VDM Verlag

£82.00 03 Nov 2026
Psychiatric and Cognitive Disorders in Parkinson's Disease (Psychiatry and Medicine)
77% match

Psychiatric and Cognitive Disorders in Parkinson's Disease (Psychiatry and Medicine)

Cambridge University Press

£117.47 03 Nov 2026
Encyclopedia of Neurodegenerative Diseases: Volume I (Disease Mechanisms): 1
77% match

Encyclopedia of Neurodegenerative Diseases: Volume I (Disease Mechanisms): 1

Hayle Medical

£72.73 22 Oct 2026
Handbook of Non-Motor Symptoms in Parkinson's Disease
77% match

Handbook of Non-Motor Symptoms in Parkinson's Disease

Springer

£39.77 24 Oct 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
77% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 22 Oct 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
77% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£108.15 30 Oct 2026
Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive
77% match

Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive

Springer

£61.98 26 Oct 2026
Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)
77% match

Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)

Elsevier

£163.99 21 Oct 2026
Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management
77% match

Neuropsychiatric and Cognitive Changes in Parkinson's Disease and Related Movement Disorders: Diagnosis and Management

Cambridge University Press

£80.38 30 Oct 2026
Psych Cog Disorders Parkinson Dis
77% match

Psych Cog Disorders Parkinson Dis

Cambridge University Press

£52.48 27 Oct 2026
Kole's Principles and Practice of Neuro-regenerative Medicine: Disease & The Parkinson's Platform
77% match

Kole's Principles and Practice of Neuro-regenerative Medicine: Disease & The Parkinson's Platform

£44.21 15 Sep 2026
Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)
77% match

Cell Transplantation for Neurological Disorders: Toward Reconstruction of the Human Central Nervous System (Contemporary Neuroscience)

Humana

£129.05 22 Oct 2026
Advances in Research on Neurodegeneration: Volume 8: 60 (Journal of Neural Transmission. Supplementa, 60)
77% match

Advances in Research on Neurodegeneration: Volume 8: 60 (Journal of Neural Transmission. Supplementa, 60)

Springer

£126.13 15 Sep 2026
Encyclopedia of Neurodegenerative Diseases: Volume III (Integrated Processes): 3
76% match

Encyclopedia of Neurodegenerative Diseases: Volume III (Integrated Processes): 3

Hayle Medical

£72.73 22 Oct 2026
Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)
76% match

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Springer

£76.42 27 Oct 2026
Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)
76% match

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Springer

£197.47 03 Nov 2026